Interview with Ingo Raimon, General Manager, AbbVie Austria
You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and dedicated? AbbVie is a…
Address: Bürohaus Neue Donau,
Wagramer Str. 4/OG 7/ Top 7
1220 Wien
,Austria
Tel: 0043-(0)171728313
Web: http://www.krka.biz/en/?utm_source=301
Krka is among top generic pharmaceutical companies in the world. We have now been successfully implementing our strategies and pursuing our mission and vision for over half a century.
Line of business
Krka’s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products. The company’s activities are supplemented by health resort and tourist services.
Markets
Our products are sold in over 70 countries. As part of our business strategy we have set the objective of balanced sales in five different regions: Slovenia, Central Europe, South-East Europe, East Europe, West Europe and Overseas Markets.
Research and development
At Krka we develop innovative generic medicines, i.e. generic medicines with value added, which are the product of our own in-house knowledge, and provide our products with major advantages for years after market entry. All our pharmaceuticals offer high quality, efficacy and safety. Our products are marketed under our own brands.
Quality
As a generic producer, Krka is responsible for medicines that can take their place alongside the world’s leading pharmaceutical companies in terms of quality, safety and efficacy. Quality, in the broadest sense of the word, is created, maintained, and the responsibility of all employees. Krka’s systematic approach is intended to ensure it exceeds customer requirements and achieve its set operating objectives.
Investment
Krka’s strategy for own-brand generic pharmaceutical development is achieved through investment in research and development capacity and Krka’s own production and distribution centres around the world.
Employee care
Krka’s business performance is based on the commitment and the knowledge of its employees. At Krka we are committed to acquiring, motivating and retaining dedicated and capable staff and building an international corporate culture. Investment in knowledge and the development of all our employees helps them to become among the very best in their own fields of work.
Prescription pharmaceuticals
Krka’s prescription pharmaceuticals are, in the great majority, the result of our own knowledge, since these are high quality generic products with added value.
Non-prescription products
Krka has an extensive portfolio of non-prescription products covering all key indications for self-medication for which people frequently seek non-prescription medications to alleviate the symptoms.
Animal health products
In the animal health field, we have more than 50 registered products. These are mainly products which act against the causative agents of infectious and parasitic diseases, feed additives, …
You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and dedicated? AbbVie is a…
LISAvienna celebrated its tenth anniversary in September. Could you briefly describe the core activities and organizational structure that has developed over the last decade? Austria has historically been quite strong…
Prior to founding Vela, you worked in a number of different positions with various companies such as Baxter and Octapharma. What opportunities did you see in founding your own company?…
Previously you worked for a pharmaceutical company, before moving to head up Eucodis Bioscience. What was your main motivation for switching from the pharmaceutical to the industrial biotech industry? The…
Could you please provide an overview of your main scope of activities in Austria and the importance of healthcare and pharmaceuticals to Boston Consulting Group’s (BCG) business model and revenue?…
Prior to joining Kedrion you worked for CSL Behring for a number of years. What opportunities did you see for yourself in moving from there to Kedrion? The biggest opportunity…
You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find…
Can you give our readers a brief overview of Daiichi Sankyo in Austria as well as its market positioning and growth factors in 2012? Daiichi Sankyo Austria GmbH is the…
How does the Austrian affiliate fit within Quintiles’ global structure, and what is the scope of the company’s activities here? Quintiles Austria was established in 1996 and has grown from…
Could you give our readers a snapshot of the association and its role in the Austrian pharmaceutical context? FOPI is a small and specialized industry association that has a homogenous…
Almirall was opened through the acquisition of Hermal in 2007. What impact did that have on Almirall’s operations in central Europe, and where does Austria fit in Almirall’s picture today?…
2012 marks the twentieth anniversary of Polymun. Can you describe to our readers the origins of the company and how it compares to your expectations in 1992? Prior to founding…
See our Cookie Privacy Policy Here